TRACE
Trace a source
tape live—manual reviewONevidenceREQUIREDjson/trace.jsontracked horizons1D · 7D · 30D · 90Ddisclaimernot financial advicetape live—manual reviewONevidenceREQUIREDjson/trace.jsontracked horizons1D · 7D · 30D · 90Ddisclaimernot financial advice
publisheddirectional thesisLONGyoutubenot an explicit trade

LLY directional thesis

Chamath counters that the deepest incumbency moat is a regulated drugmaker, since FDA-trial timelines and biologics manufacturing cannot be disrupted by software the way distribution can. 'The regulated pharma company' has no ticker, so the cleanest large-cap expression of that incumbency-moat long is Eli Lilly.

$1,097entry snapshot
pendingcurrent snapshot
— pendingsince mention
“[Jason] I'm going to take Boeing. [Chamath] Good luck making drugs out of an Excel spreadsheet. I'll take the regulated pharma company. Good luck, sir.”
1:14:51claim_id mcl_9b5b48077734eb05c4open evidence ↗
Classification directional thesis

Human-reviewed public claim.

Evidence span 1:14:51

Evidence URL, source timestamp, and excerpt are attached to this permanent claim page.

Correction path available

Creators or reviewers can request reclassification, context, or entity corrections without erasing the source record.

Machine-readable claim
{
  "version": "market-claims.v1",
  "claim": {
    "id": "mcl_9b5b48077734eb05c4",
    "url": "/trace/claims/mcl_9b5b48077734eb05c4",
    "status": "PUBLISHED",
    "claimType": "DIRECTIONAL_THESIS",
    "direction": "LONG",
    "claimText": "Chamath counters that the deepest incumbency moat is a regulated drugmaker, since FDA-trial timelines and biologics manufacturing cannot be disrupted by software the way distribution can. 'The regulated pharma company' has no ticker, so the cleanest large-cap expression of that incumbency-moat long is Eli Lilly.",
    "confidence": 0.72,
    "expert": {
      "slug": "allin",
      "displayName": "All-In Podcast",
      "kind": "PERSON",
      "status": "UNCLAIMED",
      "avatarUrl": "/api/avatars/acfd1290-a",
      "url": "/trace/experts/allin",
      "claimed": false
    },
    "primaryEntity": {
      "kind": "ASSET",
      "assetClass": "EQUITY",
      "symbol": "LLY",
      "name": "LLY",
      "exchange": null,
      "confidence": 0.78
    },
    "evidence": {
      "evidenceUrl": "https://youtu.be/4oq91rzQcO8?t=4491s",
      "sourceUrl": "https://youtube.com/watch?v=4oq91rzQcO8",
      "timecode": "1:14:51",
      "startMs": 4491000,
      "endMs": null,
      "excerpt": "[Jason] I'm going to take Boeing. [Chamath] Good luck making drugs out of an Excel spreadsheet. I'll take the regulated pharma company. Good luck, sir."
    },
    "performance": {
      "entryPrice": 1096.6650390625,
      "currentPrice": null,
      "returnPct": null,
      "relativePct": null,
      "method": "PASTE_AUTHOR_PRICE"
    },
    "resolutionStatus": "OPEN",
    "ambiguityNotes": null,
    "horizon": "multi-year",
    "isExplicitTrade": false,
    "notFinancialAdvice": true,
    "disclaimer": "AISO tracks public statements, not verified portfolio positions. This is not financial advice."
  },
  "expert": {
    "slug": "allin",
    "displayName": "All-In Podcast",
    "kind": "PERSON",
    "status": "UNCLAIMED",
    "avatarUrl": "/api/avatars/acfd1290-a",
    "url": "/trace/experts/allin",
    "claimed": false
  },
  "source": {
    "platform": "YOUTUBE",
    "title": "All-In E275: The Pope's AI Encyclical, Anthropic's \"Dr. Frankenstein\" Theory, AI Jobs Debate",
    "sourceUrl": "https://youtube.com/watch?v=4oq91rzQcO8",
    "publishedAt": "2026-05-29T18:00:00.000Z"
  },
  "evidence": {
    "evidenceUrl": "https://youtu.be/4oq91rzQcO8?t=4491s",
    "sourceUrl": "https://youtube.com/watch?v=4oq91rzQcO8",
    "timecode": "1:14:51",
    "startMs": 4491000,
    "endMs": null,
    "excerpt": "[Jason] I'm going to take Boeing. [Chamath] Good luck making drugs out of an Excel spreadsheet. I'll take the regulated pharma company. Good luck, sir.",
    "quote": "[Jason] I'm going to take Boeing. [Chamath] Good luck making drugs out of an Excel spreadsheet. I'll take the regulated pharma company. Good luck, sir.",
    "speaker": "Chamath Palihapitiya"
  },
  "entities": [
    {
      "kind": "ASSET",
      "assetClass": "EQUITY",
      "symbol": "LLY",
      "name": "LLY",
      "exchange": null,
      "confidence": 0.78
    }
  ],
  "marketData": {
    "entry": {
      "price": 1096.6650390625,
      "currency": "USD",
      "observedAt": "2026-05-29T18:00:00.000Z",
      "method": "PASTE_AUTHOR_PRICE"
    },
    "current": null,
    "returnPct": null
  },
  "snapshots": [
    {
      "kind": "ENTRY",
      "symbol": "LLY",
      "assetClass": "EQUITY",
      "price": 1096.6650390625,
      "probability": null,
      "currency": "USD",
      "provider": "paste.trade",
      "providerSymbol": "LLY",
      "observedAt": "2026-05-29T18:00:00.000Z",
      "method": "PASTE_AUTHOR_PRICE",
      "returnPct": null,
      "relativePct": null
    }
  ]
}

AISO Market Calls classifies public statements from public sources. A classification such as long thesis, short thesis, or explicit call describes the content of the public statement and does not prove that the speaker actually entered, exited, or held a position. Market performance shown is calculated from public market data around the source publication or timestamp. It is not investment advice.